Oxford BioDynamics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Oxford BioDynamics generated cash of -$8,294,000, which is less than the previous year. Cash used in financing activities reached the amount of $13,420,000 last year. Net change in cash is therefore $4,276,000.
Cash Flow
| 2014 | -424K | 1K | 2.92M |
|---|---|---|---|
| 2015 | -1.22M | -452K | 4.5M |
| 2016 | -1.34M | -155K | -81K |
| 2017 | -1.52M | -320K | 5.4M |
| 2018 | -1.94M | -678K | 10.03M |
| 2019 | -2.27M | -11.18M | 236K |
| 2020 | -3.40M | 4.58M | -181K |
| 2021 | -5.91M | 2.82M | -804K |
| 2022 | -5.17M | 1.25M | 2.56M |
| 2023 | -8.29M | -691K | 13.42M |
OBD.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 974K | 2.17M | 6.11M | 5.19M | 18.27M | 10.79M | 7.27M | 8.43M | 5.49M | 3.01M |
Operating activities | ||||||||||
Net income | -10.82M | -7.56M | -7.62M | -4.91M | -3.38M | -2.42M | -3.80M | -1.73M | -1.00M | -736K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.35M | 1.21M | 1.08M | 467K | 387K | 331K | 242K | 166K | 93K | 48K |
Stock-based compensation expense | 332K | 394K | 251K | 253K | 274K | 0 | 398K | 402K | 344K | 128K |
| Deferred income tax benefit | 332K | 394K | 251K | 253K | 274K | 0 | 398K | 402K | 344K | 128K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -448K | 469K | -560K | 136K | -14K | -100K | 147K | -214K | 0 | 0 |
Inventories | 63K | 55K | -69K | -80K | -97K | -56K | 16K | -43K | -40K | -23K |
Accounts payable | -286K | 475K | 416K | 165K | 381K | -316K | 243K | 69K | 0 | 0 |
Cash generated by operating activities | -8.29M | -5.17M | -5.91M | -3.40M | -2.27M | -1.94M | -1.52M | -1.34M | -1.22M | -424K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 107K | 0 | -4.91M | -10.3M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -250K | -901K | -3.08M | -457K | -632K | -776K | -425K | -208K | -523K | -38K |
Acquisitions Net | 0 | -107K | 0 | 1K | -422K | 12K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -691K | 1.25M | 2.82M | 4.58M | -11.18M | -678K | -320K | -155K | -452K | 1K |
Financing activities | ||||||||||
Common Stock Issued | 15.38M | 3.62M | 0 | 0 | 236K | 10.04M | 7.10M | 0 | 4.5M | 2.92M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 13.42M | 2.56M | -804K | -181K | 236K | 10.03M | 5.4M | -81K | 4.5M | 2.92M |
Net Change In Cash | 4.27M | -1.20M | -3.94M | 921K | -13.08M | 7.48M | 3.51M | -1.15M | 2.93M | 2.48M |
Cash at end of period | 5.25M | 974K | 2.17M | 6.11M | 5.19M | 18.27M | 10.79M | 7.27M | 8.43M | 5.49M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |